EWTX Operating Cash Flow (Statement)
Edgewise Therapeutics Inc · Operating Cash Flow (Statement)
EWTX Operating Cash Flow (Statement)
Latest reported-$159.42Mperiod ending
EWTX TTM Cash from Operations (-$14.63M → -$159.42M)
TTM operating cash flow (statement)
High-resolution chart · PNG
EWTX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -159,421,000 | |
| -148,493,000 | |
| -143,816,000 | |
| -132,181,000 | |
| -124,779,000 | |
| -118,296,000 | |
| -109,028,000 | |
| -108,901,000 | |
| -103,585,000 | |
| -97,720,000 | |
| -91,948,000 | |
| -76,938,000 | |
| -66,878,000 | |
| -62,889,000 | |
| -52,635,000 | |
| -50,234,000 | |
| -46,498,000 | |
| -40,022,000 | |
| -33,507,000 | |
| -28,726,000 | |
| -23,736,000 | |
| -17,952,000 | |
| -14,634,000 |